Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Increased fatty acid delivery by tumor endothelium promotes metastatic outgrowth
Deanna N. Edwards, Shan Wang, Kelby Kane, Wenqiang Song, Laura C. Kim, Verra M. Ngwa, Yoonha Hwang, Kevin Ess, Mark R. Boothby, Jin Chen
Deanna N. Edwards, Shan Wang, Kelby Kane, Wenqiang Song, Laura C. Kim, Verra M. Ngwa, Yoonha Hwang, Kevin Ess, Mark R. Boothby, Jin Chen
View: Text | PDF
Research Article Immunology Metabolism Oncology

Increased fatty acid delivery by tumor endothelium promotes metastatic outgrowth

  • Text
  • PDF
Abstract

Metastatic outgrowth in distant microscopic niches requires sufficient nutrients, including fatty acids (FAs), to support tumor growth and to generate an immunosuppressive tumor microenvironment (TME). However, despite the important role of FAs in metastasis, the regulation of FA supply in metastatic niches has not been defined. In this report, we show that tumor endothelium actively promotes outgrowth and restricts antitumor cytolysis by transferring FAs into developing metastatic tumors. We describe a process of transendothelial FA delivery via endosomes that requires mTORC1 activity. Thus, endothelial cell–specific targeted deletion of Raptor (RptorECKO), a unique component of the mTORC1 complex, significantly reduced metastatic tumor burden that was associated with improved markers of T cell cytotoxicity. Low-dose everolimus that selectively inhibited endothelial mTORC1 improves immune checkpoint responses in metastatic disease models. This work reveals the importance of transendothelial nutrient delivery to the TME, highlighting a future target for therapeutic development.

Authors

Deanna N. Edwards, Shan Wang, Kelby Kane, Wenqiang Song, Laura C. Kim, Verra M. Ngwa, Yoonha Hwang, Kevin Ess, Mark R. Boothby, Jin Chen

×

Figure 2

Long-chain fatty acids are reduced upon loss of Raptor/mTORC1 in endothelial cells.

Options: View larger image (or click on image) Download as PowerPoint
Long-chain fatty acids are reduced upon loss of Raptor/mTORC1 in endothe...
Metabolomics was performed on primary microvascular endothelial cells isolated from Rptorfl/fl mice transduced with control (WT) or Cre-recombinase (Rptor-KO) adenoviruses. Cells were collected 24 hours after infection (n = 6 per group). (A and B) Summary of significantly altered metabolites by (A) major class and (B) lipid classes in Rptor-KO versus WT endothelial cells. (C) Heatmap of lipid metabolites in WT and Rptor-KO endothelial cells. Columns represent individual samples and rows are metabolites. Long-chain fatty acids (LCFAs) and long-chain polyunsaturated fatty acids (PUFAs) are indicated. (D and E) Normalized intensities (log2 + 1) of representative (D) LCFA and (E) PUFA metabolites. The median along with the 25th and 75th percentile hinges are indicated within the box. The whiskers indicate minimum and maximum values within each group. The mean is shown as a plus sign (“+”). *P < 0.05 by 2-tailed Welch’s t test.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts